Ms. Davies, I'm sorry to interrupt you, but we have received that motion. It needs 48 hours' notice. We'll present it next.... Thank you so much.
It is very common to have motions at the committee, so thank you, Ms. Davies.
Pursuant to Standing Order 108(2), we are studying the role of government and industry in determining drug supply in Canada. We have witnesses from the Best Medicines Coalition: Gail Attara, chair of the operations committee, and president and chief executive officer of the Gastrointestinal Society; and Suzanne Nurse, a representative. Welcome, and thank you so much for being here.
From the Canadian Medical Association, we have John Haggie, the president. Welcome again. It's nice to see you here.
From Ordre des pharmaciens du Québec, we have Diane Lamarre, president; and Manon Lambert, director general and secretary. Welcome. We're so glad you could make it.
From the Canadian Society of Hospital Pharmacists, we have Myrella Roy, executive director. Welcome. We're glad you're here as well.
We have, via video conference from Buenos Aires, Argentina, from the Canadian Anesthesiologists' Society, Richard Chisholm, president.
Mr. Chisholm, welcome. Thank you so much for being here. We're very honoured to have you join our committee.
We will begin. We'll have a ten-minute presentation from all participants.
Mr. Chisholm, please make your presentation.